102 related articles for article (PubMed ID: 22634186)
1. Structural characterization of the PliG lysozyme inhibitor family.
Leysen S; Vanderkelen L; Van Asten K; Vanheuverzwijn S; Theuwis V; Michiels CW; Strelkov SV
J Struct Biol; 2012 Oct; 180(1):235-42. PubMed ID: 22634186
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of bacterial defense against host lysozymes: X-ray structures of periplasmic lysozyme inhibitors PliI and PliC.
Leysen S; Van Herreweghe JM; Callewaert L; Heirbaut M; Buntinx P; Michiels CW; Strelkov SV
J Mol Biol; 2011 Feb; 405(5):1233-45. PubMed ID: 21146533
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the inhibition of human lysozyme by PliC from Brucella abortus.
Um SH; Kim JS; Kim K; Kim N; Cho HS; Ha NC
Biochemistry; 2013 Dec; 52(51):9385-93. PubMed ID: 24308818
[TBL] [Abstract][Full Text] [Related]
4. The structure of the proteinaceous inhibitor PliI from Aeromonas hydrophila in complex with its target lysozyme.
Leysen S; Van Herreweghe JM; Yoneda K; Ogata M; Usui T; Araki T; Michiels CW; Strelkov SV
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):344-51. PubMed ID: 25664745
[TBL] [Abstract][Full Text] [Related]
5. Identification of a bacterial inhibitor against g-type lysozyme.
Vanderkelen L; Van Herreweghe JM; Vanoirbeek KG; Baggerman G; Myrnes B; Declerck PJ; Nilsen IW; Michiels CW; Callewaert L
Cell Mol Life Sci; 2011 Mar; 68(6):1053-64. PubMed ID: 20734102
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of bacterial defense against g-type lysozyme-based innate immunity.
Leysen S; Vanderkelen L; Weeks SD; Michiels CW; Strelkov SV
Cell Mol Life Sci; 2013 Mar; 70(6):1113-22. PubMed ID: 23086131
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the recognition of lysozyme by MliC, a periplasmic lysozyme inhibitor in Gram-negative bacteria.
Yum S; Kim MJ; Xu Y; Jin XL; Yoo HY; Park JW; Gong JH; Choe KM; Lee BL; Ha NC
Biochem Biophys Res Commun; 2009 Jan; 378(2):244-8. PubMed ID: 19028453
[TBL] [Abstract][Full Text] [Related]
8. The catalytic domain of a bacterial lytic transglycosylase defines a novel class of lysozymes.
Thunnissen AM; Isaacs NW; Dijkstra BW
Proteins; 1995 Jul; 22(3):245-58. PubMed ID: 7479697
[TBL] [Abstract][Full Text] [Related]
9. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria.
Abergel C; Monchois V; Byrne D; Chenivesse S; Lembo F; Lazzaroni JC; Claverie JM
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6394-9. PubMed ID: 17405861
[TBL] [Abstract][Full Text] [Related]
10. Role of lysozyme inhibitors in the virulence of avian pathogenic Escherichia coli.
Vanderkelen L; Ons E; Van Herreweghe JM; Callewaert L; Goddeeris BM; Michiels CW
PLoS One; 2012; 7(9):e45954. PubMed ID: 23049900
[TBL] [Abstract][Full Text] [Related]
11. Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors.
Voet A; Callewaert L; Ulens T; Vanderkelen L; Vanherreweghe JM; Michiels CW; De Maeyer M
Biochem Biophys Res Commun; 2011 Feb; 405(4):527-32. PubMed ID: 21256115
[TBL] [Abstract][Full Text] [Related]
12. Protecting Gram-negative bacterial cell envelopes from human lysozyme: Interactions with Ivy inhibitor proteins from Escherichia coli and Pseudomonas aeruginosa.
Liu Z; García-Díaz B; Catacchio B; Chiancone E; Vogel HJ
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3032-46. PubMed ID: 25838125
[TBL] [Abstract][Full Text] [Related]
13. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria.
Callewaert L; Aertsen A; Deckers D; Vanoirbeek KG; Vanderkelen L; Van Herreweghe JM; Masschalck B; Nakimbugwe D; Robben J; Michiels CW
PLoS Pathog; 2008 Mar; 4(3):e1000019. PubMed ID: 18369469
[TBL] [Abstract][Full Text] [Related]
14. Structural evidence for lack of inhibition of fish goose-type lysozymes by a bacterial inhibitor of lysozyme.
Kyomuhendo P; Nilsen IW; Brandsdal BO; Smalås AO
J Mol Model; 2008 Sep; 14(9):777-88. PubMed ID: 18491152
[TBL] [Abstract][Full Text] [Related]
15. Identification and expression analysis of three c-type lysozymes in Oreochromis aureus.
Gao FY; Qu L; Yu SG; Ye X; Tian YY; Zhang LL; Bai JJ; Lu M
Fish Shellfish Immunol; 2012 May; 32(5):779-88. PubMed ID: 22343107
[TBL] [Abstract][Full Text] [Related]
16. High-resolution structures of Escherichia coli cDsbD in different redox states: A combined crystallographic, biochemical and computational study.
Stirnimann CU; Rozhkova A; Grauschopf U; Böckmann RA; Glockshuber R; Capitani G; Grütter MG
J Mol Biol; 2006 May; 358(3):829-45. PubMed ID: 16545842
[TBL] [Abstract][Full Text] [Related]
17. The SufE sulfur-acceptor protein contains a conserved core structure that mediates interdomain interactions in a variety of redox protein complexes.
Goldsmith-Fischman S; Kuzin A; Edstrom WC; Benach J; Shastry R; Xiao R; Acton TB; Honig B; Montelione GT; Hunt JF
J Mol Biol; 2004 Nov; 344(2):549-65. PubMed ID: 15522304
[TBL] [Abstract][Full Text] [Related]
18. Protein flexibility and adaptability seen in 25 crystal forms of T4 lysozyme.
Zhang XJ; Wozniak JA; Matthews BW
J Mol Biol; 1995 Jul; 250(4):527-52. PubMed ID: 7616572
[TBL] [Abstract][Full Text] [Related]
19. Identification and expression analysis of the g-type and c-type lysozymes in grass carp Ctenopharyngodon idellus.
Ye X; Zhang L; Tian Y; Tan A; Bai J; Li S
Dev Comp Immunol; 2010 May; 34(5):501-9. PubMed ID: 20034515
[TBL] [Abstract][Full Text] [Related]
20. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme.
Van Herreweghe JM; Vanderkelen L; Callewaert L; Aertsen A; Compernolle G; Declerck PJ; Michiels CW
Cell Mol Life Sci; 2010 Apr; 67(7):1177-88. PubMed ID: 20049505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
